Biden wanted Medicaid to pay for weight-loss drugs. Trump just said it doesn’t have to.

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, state Medicaid programs will retain the choice of whether to cover the high-priced medications for their residents.